KSHV通过FAM50A重新编程宿主RNA剪接,以激活STAT3并驱动瘤细胞转化
Shenyu Sun1,2,3, Ling Ding1,2, Karla Paniagua4
1Cancer Virology Program, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.
mBio
|June 12, 2025
概括
卡波西的肉瘤相关性疹病毒 (KSHV) 劫持RNA拼接,使用蛋白质FAM50A来改变基因表达并促进癌症. 破坏这个过程,特别是SHP2剪接,会抑制KSHV驱动的细胞生长和转化.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 病毒学 病毒学
背景情况:
- RNA替代拼接在细胞过程和癌症发育中至关重要.
- 卡波西的肉瘤相关性疹病毒 (KSHV) 与人类恶性瘤有关,特别是在艾滋病患者中.
- 了解KSHV在通过拼接的细胞转化中的作用至关重要.
研究的目的:
- 为了确定参与KSHV诱导的细胞转换的关键拼接因素.
- 为了阐明KSHV驱动的接重编程在瘤发生的机制.
- 研究FAM50A在KSHV介导的转化和癌症中的作用.
主要方法:
- 在KSHV转化细胞中进行CRISPR-Cas9查.
- 转录组测序以识别差异性替代拼接的转录.
- 对KSHV突变和FAM50A淘汰/淘汰模型的分析.
主要成果:
- 确定了131个不同的替代拼接转录,主要是通过异构跳转.
- 发现FAM50A对于KSHV介导的转化,增殖和瘤产生至关重要.
- FAM50A淘汰赛改变了SHP2拼接,影响了STAT3酸化和瘤信号.
结论:
- KSHV操纵宿主RNA拼接机器,特别是FAM50A介导的SHP2拼接,以驱动瘤转化.
- FAM50A对KSHV驱动的扩散和瘤发生至关重要.
- 针对KSHV诱导的拼接变化,就像FAM50A的作用一样,提供了潜在的治疗策略.
关键词:
在FAM50A中使用.卡波西的肉瘤 (KS)卡波西的肉瘤相关的疹病毒,KSHV.通过RNA拼接进行RNA拼接.在 SHP2 中, SHP2 是 SHP2.在STAT3激活过程中,细胞转化细胞的转化.更多相关视频
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
5.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.0K
Mechanisms of Retrovirus-induced Cancers
5.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K


